The Expanding Class of GLP-1 Receptor Agonists: A Clinical Reading

The GLP-1 receptor agonist class continues to expand. Clinical decision-making has to keep pace with both new evidence and new molecules.

Key findings

• Effect sizes vary substantially across studies.
• Applicability to healthy adults remains contingent on further evidence.
• Careful monitoring is warranted when interventions are used off-label.

Clinical context

Recommendations should always be considered within the individual patient's clinical picture.

Limitations

Publication bias, heterogeneous protocols, and short follow-up limit strong conclusions.

References

1. Author et al. Journal Placeholder. Year. Volume, Pages.
2. Author et al. Journal Placeholder. Year. Volume, Pages.